Home > Official notices > Disciplinary Committee  |  Search

PJ Online homeThe Pharmaceutical Journal
Vol 279 No 7468 p275
8 September 2007


Disciplinary Committee

The Disciplinary Committee of the Royal Pharmaceutical Society will meet at 1 Lambeth High Street, London, SE1, on Monday 10, Tuesday 11, Thursday 13 and Friday 14 September 2007 to hear the following matters:

1. The Committee will hear the new inquiry into a complaint by the Council of the Society against Lawrence Simpson Mason (registration number 68483) which alleges that the supply of 28 Lansoprazole 15mg capsules against a prescription calling for 28 Lansoprazole 30mg capsules on four occasions; supplying half of the prescribed dose without the approval of the prescriber or any other doctor at the prescribing surgery and by responding to a letter submitting inaccurate information in regards to the above, may amount to misconduct.

2. An application for restoration to the register on behalf of Ramesh Mavji Patel (previous registration number 90343).

3. The Committee will hear the new inquiry into Mark David Bowyer (Registration number 76990) who on 19 May 2006 in the Crown Court at Derby was convicted of three counts of supplying a Class B controlled drug and five counts of supplying a Class C controlled drug.

4. The Committee will hear the new inquiry into a complaint by the Council of the Society against Alexander Harper (Registration number 75295) which alleges that attending work as a pharmacist in charge, when unfit to do so, may amount to misconduct.

The Disciplinary Committee of the Royal Pharmaceutical Society met on Friday 31 August 2007 and made the following direction:

1. Following an inquiry into Sunil Paul Khanna (registration number 75526) and Anil Paul Khanna (registration number 75094), the Committee directed the removal of the above from the Register. Under Section 11 of the Pharmacy Act 1954, the direction to remove Mr A Khanna’s and Mr S Khanna’s names from the Register is not to take effect until the expiration of a period of three months from the date on which notice of removal was given or in a case where an appeal has been brought against the direction, until the appeal is determined or withdrawn.

Fitness to Practise
Committees Secretariat

Back to Top


©The Pharmaceutical Journal